| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech, Inc. (EDSA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 2 sells. EDSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.8K | $2.79M | - | |
| Pres | 226.9K | $1.26M | - | |
| CFO | 65.0K | $360.8K | - | |
| Dir | 52.7K | $292.3K | - | |
| Dir | 30.4K | $168.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2021 | Brooks Michael J | President | Buy | 3,500 | $5.19 | $18,165.00 | +35.9% | |
| Mar 25, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $5.25 | $15,750.00 | +0.6% | |
| Mar 24, 2021 | Brooks Michael J | President | Buy | 4,500 | $5.08 | $22,860.00 | +85.9% | |
| Mar 24, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $5.16 | $25,800.00 | +0.9% | |
| Feb 18, 2021 | Oakes Frank R. | Director | Sell | 7,992 | $7.25 | $57,942.00 | -100% | |
| May 27, 2020 | Brooks Michael J | President | Buy | 2,500 | $3.00 | $7,498.50 | +48.5% | |
| May 26, 2020 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $2.98 | $8,939.10 | +0.1% | |
| Mar 29, 2020 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $5.23 | $10,460.00 | +0.4% | |
| Mar 17, 2020 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $1.87 | $9,373.10 | - | |
| Jan 8, 2020 | Johnson Lorin K | Director | Buy | 8,524 | $4.11 | $35,033.64 | New |